CEO Executive AssistantM&A as a CEO-Led Strategic Initiative
Mergers and acquisitions represent one of the most consequential strategic decisions an insurance CEO makes. Whether acquiring a book of business, purchasing a competing insurer, acquiring distribution capabilities, or buying a technology company, M&A transactions reshape the company’s competitive position, alter its financial profile, and test its integration capabilities.
The CEO’s personal involvement in M&A is non-negotiable at the strategic level. Target identification, deal rationale, price discipline, and integration strategy are CEO-level judgments that cannot be delegated. Yet the mechanics of deal execution, including due diligence, legal documentation, regulatory approvals, and integration planning, involve hundreds of decisions across dozens of functions that the CEO cannot personally manage.
Effective M&A delegation means maintaining the CEO’s decisive hand on strategic direction while empowering skilled M&A and functional leaders to execute the operational dimensions of deals efficiently.
The CEO’s Non-Delegable M&A Responsibilities
Strategic rationale. The CEO must be able to articulate clearly and convincingly why a particular acquisition creates value: what capabilities it adds, what markets it opens, what scale advantages it creates, and how it advances the company’s strategic direction. If the CEO cannot explain this confidently, the deal should not proceed.
Target selection. The decision to pursue a specific acquisition target, particularly any confidential outreach or formal expression of interest, involves reputational commitments and strategic signals that belong at the CEO level.
Price discipline. In competitive M&A processes, the pressure to win deals at prices above initial estimates is intense. The CEO must personally hold the line on price discipline, setting maximum walk-away valuations and overriding any internal pressure to stretch for strategic rationale.
Board engagement. Major acquisitions require board approval. The CEO presents to the board, advocates for the transaction, and is accountable for the outcomes.
Seller relationship management. In negotiated transactions, the CEO often needs to engage directly with the selling company’s CEO or owners to build trust, resolve impasses, and signal commitment.
Building the M&A Delegation Structure
The Corporate Development Function
The CEO should delegate M&A process management to a corporate development leader, typically a Chief Strategy Officer, Head of Corporate Development, or M&A Director. This leader should be empowered to:
- Lead the market scanning process to identify potential acquisition targets
- Develop preliminary financial analyses and deal models for potential targets
- Manage early-stage conversations with potential targets or their bankers within CEO-defined parameters
- Coordinate the due diligence process, including functional team assignments and information room management
- Manage relationships with investment bankers, legal advisors, and other external advisors
- Develop integration planning frameworks and coordinate with the integration management office
The corporate development leader should report directly to the CEO given the strategic sensitivity of M&A activities.
The Due Diligence Leadership Team
Due diligence is the process that determines whether the strategic rationale holds up to scrutiny and identifies risks that affect deal pricing or structure. The CEO should delegate due diligence leadership to the appropriate functional executives:
Financial and actuarial due diligence: CFO and Chief Actuary evaluate reserve adequacy, balance sheet quality, investment portfolio, and financial projections.
Underwriting due diligence: Chief Underwriting Officer evaluates the quality of the underwriting portfolio, underwriting guidelines, and risk concentration.
Claims due diligence: Chief Claims Officer evaluates claims operations, open claim reserves, and claims handling quality.
Technology due diligence: CIO evaluates the target’s technology infrastructure, systems compatibility, and technology risks.
Legal and regulatory due diligence: General Counsel evaluates pending litigation, regulatory relationships, license status, and legal exposures.
HR and culture due diligence: CHRO evaluates the target’s talent, culture, and HR practices.
For how M&A due diligence governance integrates with the insurance enterprise governance model, the insurance company delegation framework describes how functional leaders coordinate in complex, cross-functional processes.
Delegating Regulatory Approval Processes
Insurance acquisitions require regulatory approval from state insurance departments, and potentially from the Federal Trade Commission or Department of Justice for larger transactions. The regulatory approval process involves:
Form A filings in states where the target company holds insurance licenses, requiring disclosure of the acquirer’s ownership, management, and financial condition. The General Counsel and corporate development team should manage the filing process.
State insurance department meetings. In many states, regulators will request meetings with the acquiring company’s senior leadership as part of the approval process. The CEO should personally attend the most significant regulatory meetings, with the General Counsel providing coordination.
Federal antitrust review for transactions above HSR thresholds should be managed by outside antitrust counsel under the General Counsel’s direction, with the CEO aware of any material regulatory concerns.
Integration Planning Delegation
The value of an acquisition is realized in integration. Poor integration execution destroys the value that deal analysis projected. The CEO should ensure integration planning begins during due diligence, not after closing:
Integration Management Office. For significant acquisitions, the CEO should designate an Integration Management Officer or Integration Steering Committee to lead integration planning and execution. This leader should report directly to the CEO during the integration period.
Integration workstreams. Each functional area (underwriting, claims, technology, HR, finance, distribution) should have a defined integration workstream with a functional leader accountable for executing integration within their domain.
Synergy realization tracking. The CEO and CFO should establish a formal process to track the realization of acquisition synergies against projections, with monthly reporting during the integration period.
Culture integration. Merging organizational cultures is among the most challenging and highest-risk aspects of insurance M&A. The CEO should personally lead cultural integration communications and ensure the CHRO has a deliberate culture integration strategy.
Portfolio Acquisitions and Book Transfers
Many insurance transactions involve acquiring a book of business rather than a complete company. Book of business acquisitions, run-off purchases, and assumed reinsurance transactions create a different delegation framework than whole company acquisitions:
Actuarial assessment is typically the primary due diligence focus for book acquisitions, with the Chief Actuary and reinsurance leadership evaluating reserve adequacy and risk quality.
Claims due diligence for run-off portfolios requires detailed review of open claims and potential latent exposures (particularly for older casualty books with environmental, asbestos, or other long-tail liabilities).
Regulatory approval may be streamlined for book transfers, but the General Counsel should confirm applicable state approval requirements.
For perspective on how financial services leaders manage M&A delegation and integration governance, the finance CEO delegation framework addresses acquisition strategy and integration management structures with directly applicable insights.
Divestitures and Portfolio Rationalization
M&A delegation also encompasses the disposition of businesses or books of business that no longer fit the company’s strategy. Divestiture decisions belong with the CEO, with execution delegated to corporate development and the relevant functional leaders.
The CEO should ensure the company has a clear process for evaluating strategic alternatives when a business segment is underperforming, and should not allow an underperforming segment to remain unaddressed because selling requires difficult decisions.
Conclusion
M&A delegation requires the insurance CEO to maintain decisive personal engagement at the strategic level while building a capable deal team that can execute the complex operational dimensions of transactions efficiently. The CEO who achieves this balance closes better deals, executes tighter due diligence, and captures integration value more consistently than one who is either too removed from the process or too involved in operational details.
Building corporate development capability, investing in integration management expertise, and maintaining personal price discipline are the CEO’s most important contributions to sustainable M&A value creation.
Related Reading
For further context, explore Insurance CEO Delegation for Actuarial Oversight and Insurance CEO Delegation for Agency Management.